ASAnthony E. Sisk

Anthony E. Sisk

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Anthony E. Sisk has a total of 72 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Deep Learning-based Anatomy-Aware Morph Model for Registration of Prostate Whole-Mount Histopathology to MRI

    by Fatemeh Zabihollahy, Holden H. Wu, Anthony E. Sisk, Robert E. Reiter, Steven S. Raman, Neil E. Fleshner, George M. Yousef, KyungHyun Sung

    A novel deep learning–based method for intrapatient multimodal image registration was developed that achieved high performance in aligning prostate MR and whole-mount histopathology images, facilitating accurate prostate cancer mapping.


  • Open Access

    Heterogeneous Presentations of iMCD: A Single‐Institution Case Series

    by Jaspreet Kaur, Anthony Sisk, Jonathan E. Zuckerman, Haifaa Abdulhaq

    Background: Idiopathic multicentric Castleman disease (iMCD) is a rare lymphadenopathic disorder characterized by hyperplasia of multiple lymph nodes and can be associated with a wide range of symptoms and presentations, from mild disease to life‐threatening organ failure. Varied histopathological features and heterogeneous presentation of this rare entity can make the diagnosis quite challenging for both hematologists and other specialists who may encounter patients at various stages of disease progression. Method: We analyze five different clinical presentations at our institution to demonstrate challenging routes of diagnosis and treatment complexities of iMCD. We aim to raise awareness to the importance of early diagnosis and appropriate management of this rare condition. Results: All patients in this series presented with symptomatic lymphadenopathy. We highlight one rare instance of thrombocytopenia, anasarca/ascites, fever, reticulin fibrosis or renal dysfunction, and organomegaly (TAFRO) syndrome with elusive iMCD, which illustrates the challenges in the diagnosis of this rare condition and the importance of early recognition of its symptoms to avoid decompensation of patients. We also review established treatment guidelines and response criteria to siltuximab as outlined in the international consensus treatment guidelines. Conclusion: These cases highlight the heterogeneity and challenging diagnosis of this rare cytokine‐driven hematological disorder and the role of siltuximab in the treatment of iMCD.

  • Quantitative 3-T Multiparametric MRI Parameters as Predictors of Aggressive Prostate Cancer

    by Daniel Hyeong Seok Kim, Ida Sonni, Tristan Grogan, Anthony Sisk, Vishnu Murthy, William Hsu, KyungHyun Sung, David S. Lu, Robert E. Reiter, Steven S. Raman

    Quantitative 3-T multiparametric MRI parameters correlated with and helped predict the presence of aggressive large cribriform pattern and intraductal carcinoma prostate cancer at whole-mount histopathology.


  • From Simulation to Surgery: Comprehensive Validation of an Optical Sensor for Monitoring Focal Laser Ablation of Solid Organ Tumors

    by Rory Geoghegan, Songping Sun, Griffith Hughes, Richard Tirado, Anthony Sisk, Alan Priester, Leonard Marks, Shyam Natarajan

    Solid organ tumors can be treated using focal laser ablation (FLA), in which a needle housing a laser fiber is inserted into a tumor and oncologic control is achieved through thermally induced tissue coagulation. The key advantage of this procedure over conventional approaches is that it has few side effects due to its minimally invasive nature. However, the lack of an inexpensive and accurate monitoring modality hinders widespread adoption. To address this unmet need, we have developed an optical probe capable of accurately monitoring the ablation procedure in real time, thus ensuring complete coagulation of the cancerous tissue. This is achieved by placing the probe at the desired ablation boundary and interrogating laser–tissue interaction in real time to detect the onset and propagation of the coagulation boundary. Here, we validate this novel monitoring modality through in silico, ex vivo, and in vivo studies. Monte Carlo simulation is performed to demonstrate the utility of the probe in a range of tissues including the prostate, liver, and brain. In all cases, the virtual optical probe is capable of detecting the coagulation boundary without any tissue-specific calibration. Next, an ex vivo bovine liver study is presented, in which laser ablation under optical probe monitoring is shown to be capable of creating ablation zones with a radial accuracy better than 1 mm. Finally, case studies from the first clinical trial of this technology are presented showing the successful adoption of this technique for monitoring laser ablation of prostate cancer.

  • Open Access

    Regulation of telomere homeostasis and genomic stability in cancer by N 6 -adenosine methylation (m 6 A)

    by Ji Hoon Lee, Juyeong Hong, Zhao Zhang, Bárbara de la Peña Avalos, Cecilia J. Proietti, Agustina Roldán Deamicis, Pablo Guzmán G., Hung-Ming Lam, Jose Garcia, Martine P. Roudier, et al.

    Down-regulation of HMBOX1 via METTL3-catalyzed m 6 A causes genomic instability driven by telomere dysfunction in cancer.


  • Intestinal mucormycosis initially identified by next‐generation sequencing of cell‐free DNA

    by Rachel Martin‐Blais, Saumya Pathak, Sean Fitzwater, David W. Dawson, Anthony E. Sisk, Douglas G. Farmer, Robert Venick, Nava Yeganeh

    Mucormycosis is a rare fungal infection that typically affects severely immunocompromised individuals, often resulting in significant morbidity and mortality. Although early and aggressive intervention is necessary to prevent poor outcomes, diagnosis of this infection remains difficult. We report the first case, to our knowledge, of invasive gastrointestinal mucormycosis initially identified by next‐generation sequencing of cfDNA from the blood, and discuss the various benefits and challenges which come with new molecular diagnostic techniques.


  • Prostate Microstructure in Prostate Cancer Using 3-T MRI with Diffusion-Relaxation Correlation Spectrum Imaging: Validation with Whole-Mount Digital Histopathology

    by Zhaohuan Zhang, Holden H. Wu, Alan Priester, Clara Magyar, Sohrab Afshari Mirak, Sepideh Shakeri, Amirhossein Mohammadian Bajgiran, Melina Hosseiny, Afshin Azadikhah, Kyunghyun Sung, et al.

    Diffusion-relaxation correlation spectrum imaging (DR CSI) parameters correlate with histopathologic microscopic prostate tissue compartments—epithelium, stroma, and lumen—in men with prostate cancer. Background Microstructural MRI has the potential to improve diagnosis and characterization of prostate cancer (PCa), but validation with histopathology is lacking. Purpose To validate ex vivo diffu...


  • The effect of tumor size and location on efficacy and safety of US- and CT- guided percutaneous microwave ablation in renal cell carcinomas

    by Sepideh Shakeri, Sohrab Afshari Mirak, Amirhossein Mohammadian Bajgiran, Allan Pantuck, Anthony Sisk, Preeti Ahuja, David S. Lu, Steven S. Raman

    Purpose To evaluate the effect of size and central location of the tumor on safety and efficacy of percutaneous CEUS- and CT-guided MWA in biopsy-proven renal cell carcinomas (RCCs). Materials and methods In this IRB-approved retrospective study, 69 biopsy-proven renal tumors in 56 patients, who underwent MWA in our institution from January 2013 to March 2017, were evaluated. Data collection included demographics, tumor characteristics, procedural protocols, and follow-up visits within 6 months post procedure. Primary outcomes were assessed by technical success (TS), local tumor progression (LTP), and complications. The Kaplan–Meier analysis was used for survival rate. Results Overall technical success was achieved for all 69 lesions (92.8% primary TS, 100% overall). Median nephrometry score was 8 (4–11) and median tumor size was 2.5 cm (0.8–7). Five lesions which required second ablation had significantly higher median tumor size 4 cm (P = 0.039) with the same nephrometry score. Renal function remained stable with no significant change in eGFR before or after ablation. The LTP rate was 5.8%. The most recurrent tumors were clear cell (50%) followed by papillary tumors (25%). The complication rate was 5.8% with minor complications (hematoma and pain) and no major issues. There was no significant association between nephrometry score and technical success, recurrence, or complication rates. Overall and tumor-specific survival rates were 96.7% and 100% at 11.9 months. Conclusions Image-guided MWA appears to be a safe and effective treatment regardless of nephrometry score and tumor location with high technical success, low recurrence, and complication rates.


  • Adrenal Teratoma: a Case Series and Review of the Literature

    by Eric J. Kuo, Anthony E. Sisk, Zhiming Yang, Jiaoti Huang, Michael W. Yeh, Masha J. Livhits

    Adrenal teratomas are rare neoplasms and there is limited data on their surgical outcomes and long-term prognosis. We aimed to review our institutional experience and compare this to the existing literature on adrenal teratomas in adults and children. An institutional pathology database was searched for cases of adrenal teratoma (June 1956–July 2016). Clinical and imaging data were abstracted from the medical records and pathology slides were obtained for review. In addition, a PubMed search for “adrenal teratoma” from June 1952 to July 2016 was performed to identify reports of primary adrenal teratoma in patients of all ages. Of 7706 patients who underwent adrenalectomy during the study period at our institution, three patients were identified with adrenal teratoma. Patients were 24, 26, and 29 years of age, respectively. Two patients presented with abdominal pain and two of the three underwent a laparoscopic adrenalectomy. A pathologic examination revealed mature cystic teratomas that frequently displayed well-differentiated respiratory, digestive, and squamous epithelia. Eighteen case reports in the literature were identified in patients 17–61 years of age. Patients presented most frequently with abdominal or flank pain (63.6%). Median tumor diameter was 9.0 cm and tumors were frequently left-sided (81.8%), cystic (63.6%), and calcified (72.7%) on either radiologic or pathologic examination. Primary adrenal teratomas are rare neoplasms that typically present as large, left-sided nodules with cystic and calcified components seen radiographically. Although the data are limited, they are generally amenable to laparoscopic resection and have a very favorable prognosis.